2seventy Bio Stock Fundamentals
| TSVT Stock | USD 4.80 0.20 4.00% |
2Seventy Bio fundamentals help investors to digest information that contributes to 2Seventy Bio's financial success or failures. It also enables traders to predict the movement of 2Seventy Stock. The fundamental analysis module provides a way to measure 2Seventy Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 2Seventy Bio stock.
At this time, 2Seventy Bio's Net Interest Income is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 13.1 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 226.9 M in 2024. 2Seventy | Select Account or Indicator |
2Seventy Bio Company Return On Equity Analysis
2Seventy Bio's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current 2Seventy Bio Return On Equity | -0.73 |
Most of 2Seventy Bio's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 2Seventy Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
2Seventy Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, 2Seventy Bio has a Return On Equity of -0.7334. This is 96.94% lower than that of the Biotechnology sector and 97.99% lower than that of the Health Care industry. The return on equity for all United States stocks is 136.58% higher than that of the company.
2Seventy Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 2Seventy Bio's current stock value. Our valuation model uses many indicators to compare 2Seventy Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 2Seventy Bio competition to find correlations between indicators driving 2Seventy Bio's intrinsic value. More Info.2Seventy Bio is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies . At this time, 2Seventy Bio's Return On Equity is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value 2Seventy Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for 2Seventy Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 2Seventy Bio's earnings, one of the primary drivers of an investment's value.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
2Seventy Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 2Seventy Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 2Seventy Bio's managers, analysts, and investors.Environmental | Governance | Social |
2Seventy Fundamentals
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (3.91) % | ||||
| Current Valuation | 318.44 M | ||||
| Shares Outstanding | 51.41 M | ||||
| Shares Owned By Insiders | 2.16 % | ||||
| Shares Owned By Institutions | 93.55 % | ||||
| Number Of Shares Shorted | 6.96 M | ||||
| Price To Book | 1.01 X | ||||
| Price To Sales | 2.58 X | ||||
| Revenue | 100.39 M | ||||
| Gross Profit | (183.46 M) | ||||
| EBITDA | (206.42 M) | ||||
| Net Income | (217.57 M) | ||||
| Cash And Equivalents | 357.93 M | ||||
| Cash Per Share | 9.45 X | ||||
| Total Debt | 256.67 M | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 3.88 X | ||||
| Book Value Per Share | 4.04 X | ||||
| Cash Flow From Operations | (166.86 M) | ||||
| Short Ratio | 6.59 X | ||||
| Earnings Per Share | (4.35) X | ||||
| Target Price | 10.5 | ||||
| Number Of Employees | 274 | ||||
| Beta | 1.87 | ||||
| Market Capitalization | 246.75 M | ||||
| Total Asset | 565.43 M | ||||
| Retained Earnings | (511.22 M) | ||||
| Working Capital | 177.99 M | ||||
| Net Asset | 565.43 M |
About 2Seventy Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 15.4 M | 16.2 M | |
| Total Revenue | 100.4 M | 108.8 M | |
| Cost Of Revenue | 27.2 M | 28.6 M | |
| Stock Based Compensation To Revenue | 0.32 | 0.30 | |
| Sales General And Administrative To Revenue | 0.00 | 0.00 | |
| Research And Ddevelopement To Revenue | 2.20 | 3.91 | |
| Capex To Revenue | (0.14) | (0.15) | |
| Revenue Per Share | 2.04 | 4.00 | |
| Ebit Per Revenue | (2.16) | (2.27) |
Pair Trading with 2Seventy Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 2Seventy Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 2Seventy Bio will appreciate offsetting losses from the drop in the long position's value.Moving against 2Seventy Stock
| 0.59 | SLS | Sellas Life Sciences | PairCorr |
| 0.48 | MNMD | Mind MedicineInc | PairCorr |
| 0.48 | REVBW | Revelation Biosciences | PairCorr |
The ability to find closely correlated positions to 2Seventy Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 2Seventy Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 2Seventy Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 2Seventy Bio to buy it.
The correlation of 2Seventy Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 2Seventy Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 2Seventy Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for 2Seventy Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out 2Seventy Bio Piotroski F Score and 2Seventy Bio Altman Z Score analysis. For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for 2Seventy Stock analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is 2Seventy Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 2Seventy Bio. If investors know 2Seventy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 2Seventy Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.35) | Revenue Per Share 1.385 | Quarterly Revenue Growth (0.70) | Return On Assets (0.21) | Return On Equity (0.73) |
The market value of 2Seventy Bio is measured differently than its book value, which is the value of 2Seventy that is recorded on the company's balance sheet. Investors also form their own opinion of 2Seventy Bio's value that differs from its market value or its book value, called intrinsic value, which is 2Seventy Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 2Seventy Bio's market value can be influenced by many factors that don't directly affect 2Seventy Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 2Seventy Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 2Seventy Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 2Seventy Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.